Boehringer Ingelheim and GoodRx partner to offer a 92% discount on biosimilar Adalimumab-adbm through GoodRx's platform for improved access and affordability.
Boehringer Ingelheim and GoodRx partner to offer a 92% discount on biosimilar Adalimumab-adbm, a citrate-free formulation of Humira, through GoodRx's platform. Priced at $550 for a 2-pack, the initiative aims to improve access and affordability for patients without insurance or with limited coverage, potentially speeding up treatment time. This partnership marks the first biosimilar to be available exclusively on GoodRx's platform, accessible at over 70,000 retail pharmacies nationwide.
July 18, 2024
6 Articles